Planta Med 2002; 68(9): 804-807
DOI: 10.1055/s-2002-34401
Original Paper
Biochem./Physiol.
© Georg Thieme Verlag Stuttgart · New York

Transport of Amentoflavone Across the Blood-Brain Barrier in vitro

H. Gutmann1 , R. Bruggisser2 , W. Schaffner2 , K. Bogman1 , A. Botomino1 , J. Drewe1
  • 1Dept. of Research and Div. of Clinical Pharmacology and Toxicology, University Hospital, Basel, Switzerland and Institute of Clinical Pharmacy, University of Basel, Switzerland
  • 2Department of Pharmacy, Institute of Pharmaceutical Biology, University of Basel, Switzerland
Weitere Informationen

Publikationsverlauf

Received: December 19, 2001

Accepted: March 29, 2002

Publikationsdatum:
30. September 2002 (online)

Abstract

The biflavone amentoflavone is an ingredient of Hypericum perforatum L. (Clusiaceae), a plant which is widely used for the treatment of mild to moderate depression. Amentoflavone inhibits the binding of flumazenil to the benzodiazepine binding site of the GABAA-receptor (IC50 = 14.9 nM). Since it has to pass the blood-brain barrier (BBB) before reaching this receptor, the penetration of [3 H]-amentoflavone through BBB was studied in an in vitro model consisting of primary cell cultures of porcine brain capillary endothelial cells (BCEC). Concentration-dependent uptake (37 - 2000 nM) was neither saturable nor temperature-sensitive indicating passive diffusion as the major uptake mechanism. This finding was confirmed by transport experiments through BCEC monolayers (> 2 % of applied dose was transported after 30 min). Co-administration of Hypericum extract increased amentoflavone transport significantly (amentoflavone alone: permeability coefficient Papp = 4.59·10-6 cm/s; co-administrated sucrose: Papp = 3.22·10-6 cm/s; amentoflavone together with hypericum: Papp = 6.74·10-6 cm/s, co-administrated sucrose Papp = 5.49·10-6 cm/s) indicating that Hypericum constituents enhance amentoflavone transport possibly by modulating paracellular permeability. Experiments with the P-glycoprotein (P-gp) overexpressing cell line P388-MDR showed that amentoflavone uptake was significantly enhanced by addition of the P-gp inhibitor verapamil, suggesting a P-gp mediated back-transport out of the cells. In conclusion, our findings show, that amentoflavone is able to pass the blood-brain barrier in vitro by passive diffusion.

References

  • 1 Baureithel K H, Berger Büter K, Engesser A, Burkard W, Schaffner W. Inhibition of benzodiazepine binding in vitro by amentoflavone, a constituent of various species of Hypericum .  Pharmaceutica Acta Helvetiae. 1997;  72 153-7
  • 2 Nielsen M, Frokjaer S, Braestrup C. High affinity of the naturally-occurring biflavonoid, amentoflavone, to brain benzodiazepine receptors in vitro .  Biochemical Pharmacology. 1988;  37 3285-7
  • 3 Audus K L, Borchardt R T. Characteristics of the large amino acid transport system of bovine brain microvessel endothelial cell monolayers.  J Neurochem. 1986;  47 484-8
  • 4 Török M, Huwyler J, Drewe J, Gutmann H, Fricker G. Transport of the β-lactam antibiotic benzylpenicillin and the dipeptide glycylsarcosine by brain capillary endothelial cells in vitro. Drug Metab.  Disp.. 1998;  26 1144-8
  • 5 Boesch D, Gavériaux C, Jachez B, Pourtier-Manzanedo A, Bollinger P, Loor F. In vivo circumvention of P-glycoprotein-mediated multidrug resistance of tumor cells with SDZ PSC 833.  Cancer Res.. 1991;  51 4226-30
  • 6 Butterweck V, Petereit F, Winterhoff H, Nahrstedt A. Solubilized hypericin and pseudohypericin from Hypericum perforatum exert antidepressant activity in the forced swimming test.  Planta Med.. 1998;  64 291-4

Prof. Dr. J. Drewe

Department of Clinical Pharmacology and Toxicology

University Hospital/Kantonsspital

Petersgraben 4

4031 Basel, Switzerland

eMail: juergen.drewe@unibas.ch

    >